Norbert Bischofberger, Kronos Bio CEO
Driving to the $278M mark on raises, a legendary R&D expert sets his sights on another pivotal goal line
Thinking back on his arrival at a fledgling Kronos Bio a little more than 2 years ago, Norbert Bischofberger — otherwise known as employee #5 — was acutely aware of the work that needed to be done.
“When I started,” he says, “there was an interesting screening methodology, but not much else.”
But for one of the world’s most accomplished R&D executives who turned biotech entrepreneur at 62, the big question is always the same: “Where’s the drug? Where’s the product?”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
